By Matt Tindall at 16 May, at 00 : 11 AM
Imaging Diagnostic Systems, Inc. (OTC:IMDS) went up 2.56%, to close at $0.0200 and its overall traded volume was 1.27M shares in the last trading session. IMDS opened at $0.02 and is trading within the range of $0.02-$0.02. The 52-week range of the stock is $0.01 – $0.05. The market capitalization of the company stands at $17.91M and it has 895.62M outstanding shares.Imaging Diagnostic Systems, Inc. (IDSI) is a development stage medical technology company. The Company is engaged in the development and testing of a Computed Tomography Laser Breast Imaging System for detecting breast cancer (CT Laser Mammography (CTLM). As of June 30, 2010, IDSI was in the process of commercializing the CTLM in certain international markets where approvals to market have been secured although CTLM is not yet approved for sale in the United States. During the fiscal year ended June 30, 2010, the Company had no revenues from its operations. The CTLM system is a CT-like scanner, but its energy source is a laser beam and not ionizing x-radiation such as is used in conventional x-ray mammography or CT scanners. IDSI’s Laser Imager for Lab Animals (LILA) program is an optical helical micro-CT scanner in a third-generation configuration.
International Assets Holding Corporation (NASDAQ:INTL) percentage change fell -3.27%, to close at $25.14 and its overall traded volume was 52,256.00 shares in the last trading session. INTL opened at $26.00 and is trading within the range of $24.82-$26.12. The 52-week range of the stock is $15.48 – $27.25. INTL’s market capitalization is $453.89M and it has 18.05M outstanding shares.INTL FCStone Inc., formerly International Assets Holding Corporation, along with its subsidiaries, provides risk management consulting services to mid-sized commercial customers, as well as provides foreign exchange and treasury services, securities execution, physical commodities trading services and execution in both listed futures and option contracts, as well as structured over-the counter (OTC) products in a range of commodities. On April 1, 2010, the Company completed the acquisition of Risk Management Incorporated and RMI Consulting, Inc. (RMI Companies). On July 2, 2010, the Company completed the acquisition of HGC Trading, LLC, HGC Asset Management, LLC, HGC Advisory Services, LLC, Hanley Alternative Trade Group, LLC and HGC Office Services, LLC (the Hanley Companies). On September 20, 2010, the Company completed the acquisition of certain assets of Provident Group (Provident), an investment banking and advisory firm.
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) slid -0.72%, to close at $9.02 and its overall traded volume was 863,222.00 shares in the last trading session. ISIS shares were trading within the range of $8.98-$9.22 while its opening price was $9.10. The 52-week range of the stock is $7.59 – $10.63. ISIS’s market capitalization is $897.84M and it has 99.59M outstanding shares.Isis Pharmaceuticals, Inc. (Isis) is engaged in antisense technology, exploiting a drug discovery platform created to generate first-in-class drugs. The Company operates in two business segments: Drug Discovery and Development, and Regulus Therapeutics Inc. (Regulus). Within the drug discovery and development segment, Isis is exploiting a drug discovery platform created to generate a range of first-in-class drugs for the Company and its partners. Isis can identify drugs, providing targets to treat a range of diseases. As of December 31, 2009, the Company have 22 drugs in development. Regulus is focused on the discovery, development and commercialization of micro ribonucleic acid (RNA) therapeutics. In January 2009, the Company completed the sale of Ibis Biosciences, Inc. to Abbott Molecular Inc. (AMI).
Itron, Inc. (NASDAQ:ITRI) percentage change grew 1.09%, to close at $54.92 and its overall traded volume was 480,512.00 shares in the last trading session. ITRI opened the day at $54.61, it made an intraday low of $54.09 and an intraday high of $55.26. The stock has a 52 week low of $50.76 and 52 week high of $78.45. The market capitalization of the company stands at $2.23B and it has 40.60M outstanding shares.Itron, Inc. (Itron) provides a portfolio of products and services to utilities for the energy and water markets worldwide. The Company, along with its subsidiaries, is a provider of metering, data collection, and utility software solutions. It has two segments: Itron North America and Itron International. Itron North America generates its revenue in the United States and Canada and offers meters and data collection and communication systems for electric, gas, and water utilities. Collection and communication systems include advanced metering infrastructures/automated meter reading (AMI/AMR) systems and a range of utility software and services. Itron International generates its revenue in Europe and South Africa, South America, and Asia/Pacific. Itron International offers a range of electricity, gas, water, and heat meters, AMR and AMI systems, software, and services. In April 2010, McKinstry acquired the Enterprise Energy Management Suite (EEM Suite) software group from Itron, Inc.
Juhl Wind, Inc. (OTC:JUHL) percentage change surged 9.17%, to close at $1.31 and its overall traded volume was 526,425.00 shares in the last trading session. JUHL shares were trading within the range of $1.25-$1.70 while its opening price was $1.31. The 52-week range of the stock is $0.70 – $1.90. At current market price, the market capitalization of the company stands at $27.94M and it has 21.33M outstanding shares.Juhl Wind, Inc. provides development, systems operation and maintenance, construction contracting, oversight and general consulting services to wind farm projects throughout the Midwestern United States. Additionally, it sells consumer-owned renewable energy products, such as remanufactured small wind turbines and solar systems. Its focus is to primarily build 5-80 Megawatt (MW) wind farms jointly owned by local communities, farm owners, environmentally concerned investors, and the Company.